3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
28
Lymphoma, Follicular
17
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Mantle-Cell
6
Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma, B-Cell
3
Leukemia
3
Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Tumor Lysis Syndrome
1
Solid Tumors
1
Recurrence
1
Oncology Patients Receiving Chemotherapy
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphoid
1
Leukemia, Hairy Cell
1
Indolent Non-Hodgkin's Lymphoma
1
Chromosome 17 deletion
1
Carcinoma, Non-Small-Cell Lung
1
B-cell Malignancies
1
Anemia
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
obinutuzumab
×
Clear all
No trials found.